Katy Slack

发表

Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice

C. Schwarzer, Lei Zhang, P. Baldock, 2014, Neuropeptides.

Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.

M. During, H. Herzog, R. Enriquez, 2006, Endocrinology.

Intermittent Moderate Energy Restriction Improves Weight Loss Efficiency in Diet-Induced Obese Mice

Lei Zhang, Amy D. Nguyen, Herbert Herzog, 2016, PloS one.

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

R. Enriquez, P. Baldock, H. Herzog, 2006, Diabetologia.

Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity.

J. Knittel, H. Herzog, E. Parker, 2006, Journal of medicinal chemistry.

Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis*

J. Eisman, M. During, Lei Zhang, 2007, Journal of Biological Chemistry.

Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion

N. Turner, Lei Zhang, R. Enriquez, 2010, International Journal of Obesity.

Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight

J. Eisman, S. Allison, M. During, 2009, PloS one.

Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways.

M. During, H. Herzog, A. Sainsbury, 2007, Endocrinology.

PYY transgenic mice are protected against diet-induced and genetic obesity

P. Baldock, H. Herzog, R. Enriquez, 2008, Neuropeptides.